Letter to the editor: global availability of mifepristone for medical abortion and ulipristal acetate for emergency contraception.

Puig Borràs C, Kapp N

Open source

DOI
10.1080/13625187.2025.2599355
Published
2026 Apr
Container
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13625187.2025.2599355,
  title = {Letter to the editor: global availability of mifepristone for medical abortion and ulipristal acetate for emergency contraception.},
  author = {Puig Borràs C and Kapp N},
  year = {2026},
  journal = {The European journal of contraception \& reproductive health care : the official journal of the European Society of Contraception},
  doi = {10.1080/13625187.2025.2599355},
  url = {https://doi.org/10.1080/13625187.2025.2599355}
}

RIS

TY  - JOUR
TI  - Letter to the editor: global availability of mifepristone for medical abortion and ulipristal acetate for emergency contraception.
AU  - Puig Borràs C
AU  - Kapp N
PY  - 2026
JO  - The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
DO  - 10.1080/13625187.2025.2599355
UR  - https://doi.org/10.1080/13625187.2025.2599355
ER  - 

APA

C, P. B., & N, K. (2026). Letter to the editor: global availability of mifepristone for medical abortion and ulipristal acetate for emergency contraception.. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception. https://doi.org/10.1080/13625187.2025.2599355

Source records